Published date: 27 February 2017
Last edited date: 27 February 2017
This notice was replaced on 27 February 2017
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 27 February 2017)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Disposable non-chemical medical consumables and haematological consumables - 33141000
Location of contract
North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Value of contract
£200,000
Procurement reference
ITT_1037
Published date
27 February 2017
Closing date
19 July 2016
Contract start date
1 December 2016
Contract end date
30 November 2020
Contract type
Supply contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
NHS Blood and Transplant is issuing this invitation to tender in connection with the competitive procurement of Cord Blood Collection Systems. This document contains important information about the Procurement Process and the Contract that the Authority intends to award.
The NHS Cord Blood Bank collects cord blood at six NHS hospitals; and is the fourth largest internationally accredited cord blood bank in the world, with the second highest percentage of rare tissue types.
Cord blood is collected Ex Utero from the umbilical cord following delivery of a baby and taken to a regulated area, where the cord blood is collected into a purpose designed bag (i.e. a Cord Blood Collection System). Once a successful collection is completed the cord blood unit is stored in a temperature controlled environment until it is transported to the Authority's evaluation facility in Colindale and then the Authority's processing facility at Filton. Cord blood is rich in stem cells and once processed can be used to treat patients who are suffering from life threatening diseases, including malignancies, bone marrow failure, haemoglobinopathies, immunodeficiencies and metabolic disorders.
More information
Attachments
-
- 20160603-ITT_1037 Offer Schedule Template-FINAL-Ver1_0-U.xls
- Offer Schedule (i.e. Pricing Template)
-
- 20160613-NHSBT0770 Specification-Kirk0015-FINAL-Ver3_0-U.doc
- User Requirement Specification (URS)
-
- ITT_1037 Summary Overview.pdf
- ITT_1037 Summary Overview
-
- 20160613-ITT_1037 Guidance and Evaluation Methodology-FINAL-Ver1_0-U.doc
- ITT_1037 Guidance and Evaluation Methodology
Links
-
- http://ted.europa.eu/udl?uri=TED:NOTICE:204760-2016:TEXT:EN:HTML&tabId=1
- Tender notice
- OJEU Contract Notice (2016/S 115-204760)
About the buyer
Contact name
Daniel Kirkbride
Address
500 North Bristol Park
Northway, Filton
Bristol
BS34 7QH
England
Telephone
01179217244
Website
Share this notice